Formation of a class of enzyme inhibitors (drugs), including a chiral compound, by using imprinted polymers or biomolecules as molecular-scale reaction vessels.
Yu
Yihua
Y
Center for Molecular Imprinting, Pure and Applied Biochemistry Chemical Center, Lund University, Sweden.
Ye
Lei
L
Haupt
Karsten
K
Mosbach
Klaus
K
D001665:Binding Sites; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000138:chemical synthesis*; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors* / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*
D004791:Enzyme Inhibitors; D011108:Polymers; D007610:Kallikreins